Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of vaginal four-strain live Lactobacillus capsules to reduce recurrence of bacterial vaginosis
ChiCTR2600125381Phase 3Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2026
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vaginal four-strain live Lactobacillus capsule in bacterial vaginosis (BV) (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: BV cumulative recurrence rate. Planned start May 2026; status: not yet recruiting.
02
Drugs
vaginal four-strain live Lactobacillus capsule
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on ChiCTR2600125381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125381.